Cargando…
Altria-Juul Labs deal: why did it occur and what does it mean for the US nicotine delivery product market
Autores principales: | Levy, David T, Sweanor, David, Sanchez-Romero, Luz Maria, O'Connor, Richard, Goniewicz, Maciej Lukasz, Borland, Ron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279136/ https://www.ncbi.nlm.nih.gov/pubmed/31484802 http://dx.doi.org/10.1136/tobaccocontrol-2019-055081 |
Ejemplares similares
-
Evidence of Nicotine Dependence in Adolescents Who Use Juul and Similar Pod Devices
por: Boykan, Rachel, et al.
Publicado: (2019) -
Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette
por: Goldenson, Nicholas I., et al.
Publicado: (2022) -
Removal of mango-flavoured Juul pods created opportunity for adulterated mango Juul-compatible pods with altered chemical constituents
por: Dell, Liam G, et al.
Publicado: (2022) -
Vaping versus JUULing: how the extraordinary growth and marketing of JUUL transformed the US retail e-cigarette market
por: Huang, Jidong, et al.
Publicado: (2019) -
Did JUUL alter the content of menthol pods in response to US FDA flavour enforcement policy?
por: Yassine, Amira, et al.
Publicado: (2022)